Skip to content

Survey on early phase trials (phase I/II) for adolescents and young adults with cancer

By the ACCELERATE « Fostering Age Inclusive Research » (FAIR) Group

1.How did you get aware of the survey?(Required.)
2.What is your role in the development of oncology early phase trials?

Check all that apply(Required.)
3.What country are you working in?(Required.)
4.Are you familiar with the ACCELERATE platform?(Required.)
Our goal is to encourage access of adolescent and young adults (AYA) into adult phase I/II innovative trials where appropriate based on the disease or mechanism of action of the drug.

We have been working to promote the inclusion of adolescents (ages 12 to 17) in adult early phase trials, when epidemiologically relevant given the targeted disease type and scientifically relevant given the mechanism of action (MoA) of the drug(s).
5.Over the last five years, have you opened any adult phase I/II early phase trials which permitted inclusion of adolescent and young adult (AYA) patients?(Required.)